TAIWAN FIRST BIOTECHNOLOGY CORP. – Trademark Portfolio

Entity Type: 03

TAIWAN FIRST BIOTECHNOLOGY CORP. has 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 4 Nice Classification classes, led by Class 29 (Meats & Processed Foods) and Class 30 (Staple Foods). This trademark owner is based in Chiayi County.

No. 12-1

Gongye 2nd Road, Minxiong Township

Chiayi County 621 , TW

14 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

TAIWAN FIRST BIOTECHNOLOGY CORP.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

29
Meats & Processed Foods (4 filings)

Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits

30
Staple Foods (4 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

32
Light Beverages (3 filings)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does TAIWAN FIRST BIOTECHNOLOGY CORP. have?

TAIWAN FIRST BIOTECHNOLOGY CORP. has 14 U.S. trademarks filed with the USPTO.

What trademark classes does TAIWAN FIRST BIOTECHNOLOGY CORP. file in?

TAIWAN FIRST BIOTECHNOLOGY CORP. files trademarks across 4 Nice Classification classes. The most active classes are Class 29 (Meats & Processed Foods), Class 30 (Staple Foods), Class 32 (Light Beverages), Class 5 (Pharmaceuticals). Class 29 covers meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits.

What is TAIWAN FIRST BIOTECHNOLOGY CORP.'s trademark registration success rate?

TAIWAN FIRST BIOTECHNOLOGY CORP. has a 0% trademark registration rate, with 0 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.